Chemed Corporation $CHE Shares Purchased by Allianz Asset Management GmbH

Key Points

• Allianz Asset Management GmbH significantly increased its position in Chemed Corporation by 145.7%, holding 15,541 shares valued at approximately $7.57 million as of its latest SEC filing.
• Chemed recently increased its quarterly dividend from $0.50 to $0.60 per share, reflecting a 0.5% dividend yield with a payout ratio of 12.34%.
• The company reported Q2 earnings that missed estimates, showing an EPS of $4.27 against a predicted $6.02, with revenue of $618.80 million compared to an expectation of $650.60 million.

Allianz Asset Management GmbH lifted its position in Chemed Corporation (NYSE:CHE - Free Report) by 145.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,541 shares of the company's stock after acquiring an additional 9,215 shares during the period. Allianz Asset Management GmbH owned 0.11% of Chemed worth $7,567,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Bessemer Group Inc. boosted its stake in shares of Chemed by 14.2% in the first quarter. Bessemer Group Inc. now owns 950 shares of the company's stock worth $585,000 after acquiring an additional 118 shares during the last quarter. DAVENPORT & Co LLC acquired a new stake in shares of Chemed in the first quarter worth approximately $265,000. Jump Financial LLC acquired a new stake in shares of Chemed in the first quarter worth approximately $2,777,000. Mather Group LLC. boosted its stake in shares of Chemed by 53.3% in the first quarter. Mather Group LLC. now owns 161 shares of the company's stock worth $99,000 after acquiring an additional 56 shares during the last quarter. Finally, Park Place Capital Corp boosted its stake in shares of Chemed by 71.2% in the first quarter. Park Place Capital Corp now owns 3,572 shares of the company's stock worth $2,198,000 after acquiring an additional 1,486 shares during the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Chemed

In other news, Director Patrick P. Grace sold 150 shares of the business's stock in a transaction dated Tuesday, September 9th. The stock was sold at an average price of $463.39, for a total value of $69,508.50. Following the completion of the sale, the director directly owned 3,397 shares of the company's stock, valued at approximately $1,574,135.83. The trade was a 4.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 3,000 shares of the business's stock in a transaction dated Friday, September 26th. The shares were sold at an average price of $461.28, for a total value of $1,383,840.00. Following the completion of the sale, the chief executive officer directly owned 96,197 shares of the company's stock, valued at $44,373,752.16. The trade was a 3.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,162 shares of company stock valued at $5,677,511 over the last quarter. Company insiders own 3.29% of the company's stock.

Chemed Price Performance

CHE opened at $441.75 on Wednesday. Chemed Corporation has a 12 month low of $408.42 and a 12 month high of $623.60. The stock has a market capitalization of $6.44 billion, a price-to-earnings ratio of 22.71, a PEG ratio of 2.59 and a beta of 0.43. The business has a fifty day moving average price of $449.11 and a 200 day moving average price of $501.36.

Chemed (NYSE:CHE - Get Free Report) last released its earnings results on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing the consensus estimate of $6.02 by ($1.75). Chemed had a return on equity of 25.83% and a net margin of 11.56%.The company had revenue of $618.80 million for the quarter, compared to analyst estimates of $650.60 million. During the same period in the previous year, the firm earned $5.47 earnings per share. The company's revenue for the quarter was up 3.8% compared to the same quarter last year. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, research analysts anticipate that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 11th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, August 11th. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. This is an increase from Chemed's previous quarterly dividend of $0.50. Chemed's payout ratio is currently 12.34%.

Analyst Ratings Changes

CHE has been the topic of a number of analyst reports. Oppenheimer lowered their price objective on Chemed from $650.00 to $580.00 and set an "outperform" rating on the stock in a research note on Thursday, July 31st. Wall Street Zen lowered Chemed from a "buy" rating to a "hold" rating in a research note on Saturday, July 5th. Jefferies Financial Group raised Chemed from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Weiss Ratings reissued a "hold (c-)" rating on shares of Chemed in a research note on Wednesday, October 8th. Finally, Royal Bank Of Canada lowered their price objective on Chemed from $640.00 to $589.00 and set an "outperform" rating on the stock in a research note on Thursday, July 31st. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $578.50.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.